跳至主要内容
临床试验/NCT04843527
NCT04843527进行中(未招募)不适用

Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People

Abbott Diabetes Care8 个研究点 分布在 1 个国家目标入组 350 人开始时间: 2021年4月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
350
试验地点
8
主要终点
Impact on time above 180 mg/dL

研究概览

简要总结

A multi-center, randomized, prospective, non-significant risk study to compare the impact of the FreeStyle Libre Flash Glucose Monitoring System with and without a food logging smartphone application on reducing time above 180 mg/dL in subjects with type 2 diabetes who are not adequately controlled on their existing oral anti-diabetes medication regimen.

详细描述

Approximately 350 subjects will be enrolled to obtain at least 84 randomized subjects,approximately 42 subjects per arm. Subjects will be randomized to use either the FreeStyle Libre Flash Glucose Monitoring System or FreeStyle Libre Flash Glucose Monitoring System with a food logging smartphone application to manage their diabetes.

The subsequent impact on reducing the amount of time spent above 180 mg/dL will be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject must be at least 18 years of age.
  • Subject has been diagnosed with type 2 diabetes.
  • HbA1c greater than or equal to 7.5% and less than or equal to 12%
  • Subject is on at least 1 diabetes medication in the classes of metformin, SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors.
  • Subject owns a compatible smartphone
  • Subject agrees to a 3-month period of no diabetes medication changes.
  • Subject is willing to make diet and lifestyle changes in response to education and glucose data

排除标准

  • Subject is currently on insulin therapy or sulfonylurea-based medications.
  • Subject has known allergy to medical grade adhesive or isopropyl alcohol used to disinfect skin.
  • Subject is known to be pregnant at the time of study enrollment (applicable to female subjects only).
  • Subject has extensive skin changes/diseases at the proposed application sites that could interfere with device placement or the accuracy of interstitial glucose measurements.

结局指标

主要结局

Impact on time above 180 mg/dL

时间窗: Three (3) months

To assess the impact of the FreeStyle Libre Flash Glucose Monitoring System with and with food logging app on time above 180 mg/dL

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

已完成
4 期
Study of Glycemic Control on Liver Transplantation OutcomesEvidence of Liver TransplantationRejectionHyperglycemia
NCT01211730Northwestern University164
已完成
不适用
New Dermal Filler for Chin Correction and AugmentationChin Augmentation and Correction
NCT04631263Galderma R&D140
已完成
不适用
Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906Wrinkle
NCT04717934Galderma R&D211
Unknown
不适用
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for ThromboembolismCancer DiagnosisThromboembolismCancer
NCT04246073Hellenic Society of Surgical Oncology400
进行中(未招募)
1 期
A randomized, multi-center study to assess the effect of Darbepoetin alfa (Aranesp®) for the treatment of anemia in patients with advanced hormone independent prostate cancer and anaemia - DANCAPepoIn an open randomised, multi-center study to identify the haematopoietic response to Aranesp® (Darbepoetin 6,75 mcg/kg) administrated every fourth week compared to standard care of treatment in patients with anaemia due to hormone refractory prostate cancer with progression of skeletal metastases. A haematopoietic response is defined as haemoglobin concentration > 12 g/dl or increase in haemoglobin > 2 g/dl during the treatment phase.MedDRA version: 6.1Level: PTClassification code 10038444
EUCTR2005-005658-37-DKDpt. of Urology -K. Aarhus University Hospital140